A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients
Clinical trial NCT02511340 · UNKNOWN
Trial details
- NCT number
- NCT02511340
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-08-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.